CPAP Devices Can Be Used as Ventilators During Coronavirus Outbreak, FDA Guidance Says

Published in Member Communities on March 24, 2020

On March 22, it was announced that new temporary guidance from the FDA allows hospitals to re-purpose existing products such as CPAP devices as ventilators in an effort to meet major shortages in the United States during the coronavirus outbreak.

The guidance allows hospitals and manufacturers to make certain modifications to existing devices, or to production lines, to create more respiratory devices.

Ventilators normally used in other environments, such as ambulances, could be used for long-term care, the guidance says. It covers devices that aren't traditionally used for long-term care.

The guidance also would allow non-medical device companies, such as auto manufacturers, to start making ventilator parts.

The agency plans to use "enforcement discretion" for modifications to FDA-cleared devices. Traditionally manufacturers' modifications to ventilators would trigger an additional pre-market review, which could delay deployment.

The guidance means "America can make more ventilators during this crisis,” Health and Human Services Secretary Alex Azar said in a release.

The guidance also aims to create "maximum regulatory flexibility" while "still providing crucial FDA oversight," FDA Commissioner Stephen Hahn said in a release.

FDA is also encouraging manufacturers, including foreign ones, to contact the agency about emergency authorizations to distribute ventilators in the United States.

Original Updates:

 

From Our Experts

U.S. Rehab Offers Live Tech Training and New ATP Training in 2025 thumbnail U.S. Rehab Offers Live Tech Training and New ATP Training in 2025 U.S. Rehab is excited to host in-person live Tech Training sessions and ATP Gateway Training in 2025. U.S. Rehab Offers Live Tech Training and New ATP Training in 2025 thumbnail U.S. Rehab Offers Live Tech Training and New ATP Training in 2025 U.S. Rehab is excited to host in-person live Tech Training sessions and ATP Gateway Training in 2025. Randy Piper Joins VGM & Associates thumbnail Randy Piper Joins VGM & Associates VGM & Associates is excited to announce Randy Piper has joined the leadership team as VP of Vendor Contract Management. A Note from Jim Greatorex: January 2025 thumbnail A Note from Jim Greatorex: January 2025 Jim shares his advice to achieving goals in 2025, both professionally and personally. A Letter from the Director: Nikki Grace thumbnail A Letter from the Director: Nikki Grace Nikki Grace, Director of OPGA, shares her vision to ensure OPGA remains a trusted resource for members and partners while continuing to elevate the O&P profession. VGM Group, Inc. Announces Acquisition of SleepGlad thumbnail VGM Group, Inc. Announces Acquisition of SleepGlad This strategic acquisition aims to enhance VGM Group's portfolio in the sleep technology sector and reinforces its commitment to delivering cutting-edge solutions to its customers. Introducing the F&P Nova Micro™: The Ultimate in Lightweight Comfort and Performance thumbnail Introducing the F&P Nova Micro™: The Ultimate in Lightweight Comfort and Performance Fisher & Paykel Healthcare has recently announced the launch of F&P Nova Micro™ nasal pillows mask for the treatment of obstructive sleep apnea (OSA) in the USA. VGM Heartland Conference Announces Website Redesign thumbnail VGM Heartland Conference Announces Website Redesign VGM is excited to unveil its newly redesigned website. Refreshed and enhanced for a more user-friendly experience, the updated site follows a more streamlined process, making all resources and information about the VGM Heartland Conference easily accessible.